Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donepezil for Walking Automaticity in Parkinson's Disease
NCT03599726Phase 1Completed
- Sponsor
- Oregon Health & Science University
- Start
- Jul 2018
- Primary completion
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in Parkinson's disease (PD) comparing Donepezil First with Placebo First (2 arms). Primary endpoint: Oxygenated Hemoglobin levels in the prefrontal cortex while walking at 43 days. Started Jul 2018; status: completed.
02
Drugs
donepezil
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT03599726.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03599726.